Table 4.
Outcome considering the presence or absence of dysregulation and clinical context.
| Clinical context | Global PR | Immune profile | Number of patients | Miscarriage rate | No pregnancy | Pregnancy rate (PR) | P-value for the PR |
|---|---|---|---|---|---|---|---|
| OD | 45% | Dysregulated | 72 | 11% | 46% | 44% | 0.64 |
| Not dysregulated | 19 | 16% | 31.6% | 52.6% | |||
| RIF-OD | 42% | Dysregulated | 113 | 14.90% | 43.80% | 41.6% | 0.56 |
| Not dysregulated | 15 | 0% | 53.3% | 46.70% | |||
| Good prognosis IVF | 56% | Dysregulated | 184 | 7.60% | 38% | 55% | 0.28 |
| Not dysregulated | 25 | 4% | 36% | 57.6% | |||
| RIF | 36% | Dysregulated | 948 | 8.40% | 53.8% | 38.4%* | 0.002 |
| Not dysregulated | 201 | 7.50% | 65.6% | 26.90% | |||
| RM | 50% | Dysregulated | 132 | 12% | 32% | 57.6%* | 0.001 |
| Not dysregulated | 33 | 24%* | 52% | 25% |
PR, Pregnancy Rate; RIF, Repeated Implantation Miscarriages; IVF, In vitro Fertilization; RM, Recurrent Miscarriages; OD, Oocyte Donation.